Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis

Annals of Hematology

Volumn 84, Issue 4, 2005, Pages 236-244

  Scholz, Christian ^a   Nimmrich, Inko ^b   Burger, Matthias ^b   Becker, Evelyne ^b   Dörken, Bernd ^a,c   Ludwig, Wolf Dieter ^c   Maier, Sabine ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EPIGENOMICS AG   (Germany)

^c Section of Pathology   (Germany)

Author keywords

Acute leukemia; Methylation; Microarray

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 2; CYCLIN D2; CYTOSINE; DNA; GUANINE; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; DNA PURIFICATION; FEMALE; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; UNINDEXED SEQUENCE;

ACUTE DISEASE; BASE SEQUENCE; CLASSIFICATION; DIAGNOSIS, DIFFERENTIAL; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, PRE-B-CELL; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS);

EID: 15844417526     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0969-1     Document Type: Article

References (49)

1. Cameron EE, Baylin SB, Herman JG (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94:2445-2451 1:CAS:528:DyaK1MXmsVCitrs%3D
2. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428 10.1038/nrg962
3. Razin A, Cedar H (1991) DNA methylation and gene expression. Microbiol Rev 55:451-458 1:CAS:528:DyaK3MXmsV2js7g%3D
4. Bird AP, Wolffe AP (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99:451-454 10.1016/S0092-8674(00)81532-9
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451-458 1:STN:280:CSiD1cjmtFU%3D
6. ES Jaffe NL Harris H Stein JW Vardiman 2001 World Health Organisation classification of tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues IARC Lyon
7. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57:837-841 1:CAS:528:DyaK2sXhs1Kisrc%3D
8. Nakayama M, Wada M, Harada T, Nagayama J, Kusaba H, Ohshima K, Kozuru M, Komatsu H, Ueda R, Kuwano M (1998) Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 92:4296-4307 1:CAS:528:DyaK1cXnslylsbY%3D
9. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB (1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56:973-977 1:CAS:528:DyaK28XhtlKksLs%3D
10. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB (1997) HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res 57:1678-1681 1:STN:280:ByiB1c%2FmvVQ%3D
11. Leegwater PA, Lambooy LH, De Abreu RA, Bokkerink JP, van den Heuvel LP (1997) DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia (ALL). Leukemia 11:971-978 10.1038/sj.leu.2400688
12. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL (1997) Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 57:832-836 1:CAS:528:DyaK2sXhs1Kisro%3D
13. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59:3352-3356 1:CAS:528:DyaK1MXks1Oms74%3D
14. Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E, Koeffler HP (1999) Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 94:1113-1120 1:CAS:528:DyaK1MXkvFCis78%3D
15. Melki JR, Vincent PC, Brown RD, Clark SJ (2000) Hypermethylation of E-cadherin in leukemia. Blood 95:3208-3213 1:CAS:528:DC%2BD3cXjt1Cjs78%3D
16. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24:132-138 10.1038/72785
17. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229 1:CAS:528:DC%2BD3MXjtFSjt7g%3D
18. Huang TH, Perry MR, Laux DE (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8:459-470 10.1093/hmg/8.3.459
19. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149 10.1038/ng892
20. Adorjan P, Distler J, Lipscher E, Model F, Muller J, Pelet C, Braun A, Florl AR, Gutig D, Grabs G, Howe A, Kursar M, Lesche R, Leu E, Lewin A, Maier S, Muller V, Otto T, Scholz C, Schulz WA, Seifert HH, Schwope I, Ziebarth H, Berlin K, Piepenbrock C, Olek A (2002) Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 30:e21 10.1093/nar/30.5.e21
21. Olek A, Oswald J, Walter J (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 24:5064-5066 10.1093/nar/24.24.5064
22. Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22:2990-2997 1:CAS:528:DyaK2cXlvFOjsL4%3D
23. KV Mardia JT Kent JM Bibby 1979 Multivariate analysis Academic London
24. Shaffer JP (1995) Multiple hypothesis testing. Annu Rev Psychol 46:561-576 10.1146/annurev.ps.46.020195.003021
25. Ihaka R, Gentleman R (1996) A language for data analysis and graphics. J Comput Graph Stat 5:299-314
26. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ (1997) Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 25:4422-4426 10.1093/nar/25.21.4422
27. Yang H, Chen CM, Yan P, Huang TH, Shi H, Burger M, Nimmrich I, Maier S, Berlin K, Caldwell CW (2003) The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas. Clin Cancer Res 9:4034-4042 1:CAS:528:DC%2BD3sXns1Ojt7Y%3D
28. Felgner J, Heidorn K, Korbacher D, Frahm SO, Parwaresch R (1999) Cell lineage specificity in G-CSF receptor gene methylation. Leukemia 13:530-534 10.1038/sj/leu/2401386
29. Wilson CB, Makar KW, Perez-Melgosa M (2002) Epigenetic regulation of T cell fate and function. J Infect Dis 185 [Suppl 1]:S37-S45 10.1086/338001
30. Chan MF, Liang G, Jones PA (2000) Relationship between transcription and DNA methylation. Curr Top Microbiol Immunol 249:75-86 1:CAS:528:DC%2BD3cXis1ykurw%3D
31. Herman JG, Jen J, Merlo A, Baylin SB (1996) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56:722-727 1:CAS:528:DyaK28XhtVCls7Y%3D
32. Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Kohler G, Wijermans P, Jones PA, Lubbert M (2002) Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100:2957-2964 10.1182/blood.V100.8.2957
33. Nyce J (1989) Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 49:5829-5836 1:CAS:528:DyaK3cXivV0%3D
34. Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM (2001) FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci U S A 98:10374-10379 10.1073/pnas.181222898
35. Li Q, Jedlicka A, Ahuja N, Gibbons MC, Baylin SB, Burger PC, Issa JP (1998) Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene 16:3197-3202 10.1038/sj.onc.1201831
36. Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, Murakumo Y, Alder H, Croce CM, Baffa R (2001) Fez1/lzts1 alterations in gastric carcinoma. Clin Cancer Res 7:1546-1552 1:CAS:528:DC%2BD3MXltV2iu7Y%3D
37. MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R (1996) Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 35:55-65 10.1006/ geno.1996.0322
38. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM (1999) The EGR family of transcription-regulatory factors: Progress at the interface of molecular and systems neuroscience. Trends Neurosci 22:167-173 10.1016/ S0166-2236(98)01343-5
39. Coleman TR, Dunphy WG (1994) Cdc2 regulatory factors. Curr Opin Cell Biol 6:877-882 10.1016/0955-0674(94)90060-4
40. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61:2782-2787 1:CAS:528:DC%2BD3MXisVSktr4%3D
41. Yu J, Leung WK, Ebert MP, Leong RW, Tse PC, Chan MW, Bai AH, To KF, Malfertheiner P, Sung JJ (2003) Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. Br J Cancer 88:1560-1565 10.1038/sj.bjc.6600940
42. Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ (1995) Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. J Virol 69:1292-1295 1:CAS:528:DyaK2MXjtlGqurw%3D
43. Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M (2003) Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 9:1446-1452 1:CAS:528:DC%2BD3sXislertLY%3D
44. Fukasawa K, Vande Woude GF (1997) Synergy between the Mos/ mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 17:506-518 1:CAS:528:DyaK2sXhtlyrsQ%3D%3D
45. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681-8686 10.1073/pnas.96.15.8681
46. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438-5442 1:CAS:528:DyaK1MXnt1Gjurw%3D
47. Liang G, Salem CE, Yu MC, Nguyen HD, Gonzales FA, Nguyen TT, Nichols PW, Jones PA (1998) DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics 53:260-268 10.1006/geno.1998.5502
48. Itano O, Ueda M, Kikuchi K, Hashimoto O, Hayatsu S, Kawaguchi M, Seki H, Aiura K, Kitajima M (2002) Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences. Oncogene 21:789-797 10.1038/sj.onc.1205124
49. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP (2001) Methylation profiling in acute myeloid leukemia. Blood 97:2823-2829 10.1182/blood.V97.9.2823